Company Description
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally.
It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments.
The company offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.
It also provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform.
Further, it develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024.
Xylo Technologies Ltd was incorporated in 1999 and is based in Tel Aviv, Israel.
| Country | Israel |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 38 |
| CEO | Liron Carmel |
Contact Details
Address: 10 Hanechoshet, 4th Floor Tel Aviv, 6971072 Israel | |
| Website | medigus.com |
Stock Details
| Ticker Symbol | XYLO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001618500 |
| ISIN Number | US58471G4091 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Liron Carmel | Chief Executive Officer |
| Tali Dinar | Chief Financial Officer |
| Ilan Oren | Executive Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 22, 2025 | 15-12G | Securities registration termination |
| Aug 22, 2025 | 25-NSE | Filing |
| Aug 22, 2025 | POS AM | Post-Effective amendments for registration statement |
| Aug 22, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 22, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 22, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 22, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 22, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 22, 2025 | 6-K | Report of foreign issuer |
| Aug 12, 2025 | SCHEDULE 13D/A | Filing |